연구성과로 돌아가기

2025 연구자 정보 (590 / 657)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Eom, Hyeon-Seok
(Eom, HS)
Natl Canc Ctr, Ctr Hematol Malignancy, Goyang, South Korea
Natl Canc Ctr, Dept Hematol Oncol, Ctr Hematol Malignancy, Goyang, South Korea
Ctr Hematol Malignancy, Natl Canc Ctr, Dept Hematol Oncol, Goyang, South Korea


[JCR상위 63.8] Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025)
SCIE
ESCI
36.2 HEMATOLOGY kihyunkimk@gmail.com; supornch@gmail.com;
kihyunkimk@gmail.com;
Heo, Hye-won
(Heo, HW)
Takeda Pharmaceut Korea Co Ltd, Med Affairs, Seoul, South Korea

[JCR상위 63.8] Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma SCIE 63.8 HEMATOLOGY kihyunkimk@gmail.com; supornch@gmail.com;
Husin, Azlan
(Husin, A)
Univ Sains Malaysia, Dept Internal Med, George Town, Gelugor, Malaysia P-4040-2019
Husin, Azlan

[JCR상위 63.8] Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma SCIE 63.8 HEMATOLOGY kihyunkimk@gmail.com; supornch@gmail.com;
Jung, Sung Hoon
(Jung, SH)
Chonnam Natl Univ, Hwasun Hosp, Dept Hematol & Oncol, Hwasun, South Korea

[JCR상위 63.8] Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma SCIE 63.8 HEMATOLOGY kihyunkimk@gmail.com; supornch@gmail.com;
Kim, Kihyun
(Kim, K)
교신저자 Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Sch Med, Seoul, South Korea
Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Hematol Oncol,Dept Med, 81 Irwon Ro, Seoul, South Korea


[JCR상위 63.8] Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025)
SCIE
ESCI
36.2 HEMATOLOGY kihyunkimk@gmail.com; supornch@gmail.com;
kihyunkimk@gmail.com;
Kim, Young-Kun
(Kim, YK)
교신저자 Kyungpook Natl Univ, Sch Appl Biosci, Daegu 41566, South Korea
Kyungpook Natl Univ, Sch Appl Biosci, Daegu, South Korea


[JCR상위 63.8] Two new species of the genus Meroplius Rondani (Diptera: Sepsidae) from Republic of Korea with a key to the Palaearctic species
[JCR상위 73.3] Faunistic study of Coleoptera (Buprestidae, Carabidae, Cerambycidae, Lucanidae and Melyridae) on Gageodo Island, south-westernmost Korean Peninsula
SCIE 63.8 ZOOLOGY
BIODIVERSITY CONSERVATION
donkey7645@naver.com; youngk804@naver.com;
ksc@knu.ac.kr;
Koh, Youngil
(Koh, Y)
Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
Seoul Natl Univ, Seoul Natl Univ Hosp, Seoul Natl Univ Hosp, Div Hematol Oncol,Coll Med, Seoul, South Korea
Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Internal Med,Div Hematol & Med Oncol, Seoul, South Korea


[JCR상위 63.8] Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions
[JCR상위 36.2] Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions (vol 60, 9, 2025)
SCIE
ESCI
36.2 HEMATOLOGY kihyunkimk@gmail.com; supornch@gmail.com;
kihyunkimk@gmail.com;
Lee, Myung-Won
(Lee, MW)
Chungnam Natl Univ Hosp, Dept Internal Med, Daejeon, South Korea

[JCR상위 63.8] Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma SCIE 63.8 HEMATOLOGY kihyunkimk@gmail.com; supornch@gmail.com;
Moon, Joon-Ho
(Moon, JH)
Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Hematol Oncol, Daegu, South Korea

[JCR상위 63.8] Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma SCIE 63.8 HEMATOLOGY kihyunkimk@gmail.com; supornch@gmail.com;
Ng, Soo Chin
(Ng, SC)
제1저자 Subang Jaya Med Ctr, Dept Haematol, Subang Jaya, Malaysia

[JCR상위 63.8] Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma SCIE 63.8 HEMATOLOGY kihyunkimk@gmail.com; supornch@gmail.com;
Park, Sung Soo
(Park, SS)
Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Hematol, Seoul, South Korea

[JCR상위 63.8] Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma SCIE 63.8 HEMATOLOGY kihyunkimk@gmail.com; supornch@gmail.com;
Shin, Ho-Jin
(Shin, HJ)
Pusan Natl Univ Hosp, Dept Internal Med, Pusan, South Korea
Pusan Natl Univ Hosp, Dept Hematol Oncol, Busan, South Korea


[JCR상위 63.8] Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma
[JCR상위 23.5] Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective study
SCIE 23.5 HEMATOLOGY
ONCOLOGY
kihyunkimk@gmail.com; supornch@gmail.com;
lee86@catholic.ac.kr;
Wahid, Sfadilah Abdul
(Wahid, SA)
Hosp Canselor Tuanku Muhriz, Pusat Terapi Sel, Kuala Lumpur, Malaysia

[JCR상위 63.8] Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma SCIE 63.8 HEMATOLOGY kihyunkimk@gmail.com; supornch@gmail.com;
Wilfred, Gilbert
(Wilfred, G)
Hosp Queen Elizabeth, Dept Med, Kota Kinabalu, Malaysia

[JCR상위 63.8] Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma SCIE 63.8 HEMATOLOGY kihyunkimk@gmail.com; supornch@gmail.com;
Amano, Mai
(Amano, M)
Takarazuka Univ Med & Hlth Care, Fac Hlth Care Sci, Dept Phys Therapy, Takarazuka, Hyogo 6660162, Japan

[JCR상위 63.9] Projections from Regions of the Cerebellar Nuclei Receiving Jaw Muscle Proprioceptive Signals to Trigeminal Motoneurons and Their Premotoneurons in the Rat Pons and Medulla SCIE 63.9 NEUROSCIENCES yoshida.atsushi.dent@osaka-u.ac.jp;
페이지 이동: